SEDANS Stock Overview
A medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Sedana Medical AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr15.79 |
52 Week High | kr0 |
52 Week Low | kr0 |
Beta | 0.26 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -11.64% |
Recent News & Updates
Recent updates
Shareholder Returns
SEDANS | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | -1.1% | -1.8% |
1Y | n/a | -9.6% | 4.2% |
Return vs Industry: Insufficient data to determine how SEDANS performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how SEDANS performed against the UK Market.
Price Volatility
SEDANS volatility | |
---|---|
SEDANS Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.8% |
Stable Share Price: SEDANS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SEDANS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 83 | Johannes Doll | www.sedanamedical.com |
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; and Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care, as well as AnaConDa, a medical device enabling administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; Scavenging tube, a one piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables to connect the exhaust of the ventilator to an active or passive scavenging system.
Sedana Medical AB (publ) Fundamentals Summary
SEDANS fundamental statistics | |
---|---|
Market cap | kr2.60b |
Earnings (TTM) | -kr22.83m |
Revenue (TTM) | kr164.91m |
15.8x
P/S Ratio-113.8x
P/E RatioIs SEDANS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SEDANS income statement (TTM) | |
---|---|
Revenue | kr164.91m |
Cost of Revenue | kr48.65m |
Gross Profit | kr116.26m |
Other Expenses | kr139.09m |
Earnings | -kr22.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 23, 2024
Earnings per share (EPS) | -0.23 |
Gross Margin | 70.50% |
Net Profit Margin | -13.85% |
Debt/Equity Ratio | 0% |
How did SEDANS perform over the long term?
See historical performance and comparison